AI tools in healthcare aim to improve clinical decisions by quickly analyzing large amounts of patient data, images, and medical guidelines. Systems like GPT-4 and other generative AI models perform well on structured medical tests, scoring between 86.3% and 89.6%. However, their accuracy drops significantly when handling open-ended clinical reasoning, especially in complex patient management requiring careful judgment.
For instance, GPT-4’s accuracy falls to about 51.2% in clinical management tasks without specific prompting. Also, nearly 35% of pharmacology-related answers were uncertain or unclear. This shows a big problem: AI does well with facts and clear scenarios but struggles with the subtle, context-based thinking needed for good patient care.
Doctors, nurses, and other healthcare workers should know that while AI can help with diagnosis and decisions, it is not ready to manage patient care by itself, especially when many factors and patient preferences are involved.
At the European Respiratory Society Congress 2024, speakers talked about worries that AI systems focus too much on measurable results instead of a patient’s personal goals and life quality. AI models often use broad data and may suggest treatments that don’t match what a patient wants. For example, some patients might want relief from symptoms or greater independence rather than aggressive treatments, something AI might not understand at first.
Getting informed consent can also be tricky. AI tools can provide personalized information or support for patients with memory or thinking problems. But many AI systems work like a “black box,” meaning it is hard for doctors to explain exactly how the AI made its suggestion. This makes it harder for patients to clearly understand their options and give true informed consent.
AI models only work well if they are trained with good data. Studies show that AI does not work equally well for all groups. Some AI systems have missed important diagnoses more often in women and racial minorities. For example, some AI tools for detecting sepsis missed 67% of actual cases, mostly affecting minority patients. This happens because the AI was trained on limited or biased data, which continues unfair differences in healthcare.
Healthcare groups need to know that unchecked bias can make inequalities worse instead of better, which is a serious problem in the diverse patient groups across the United States.
It is still not clear who should be responsible when AI causes mistakes in clinical care. Expecting healthcare workers to fully watch over AI decisions may be unrealistic because many have little training in AI and heavy workloads. Doctors and nurses learn mainly medicine, not computer science, and many feel they cannot fully understand or manage AI systems as they change.
At the same time, software makers and healthcare providers cannot avoid responsibility. This unclear sharing of liability causes legal and ethical problems for clinic managers and lawyers handling risks.
Some clinicians may trust AI too much, believing it is more accurate or fair than it really is. This “automation bias” can make them ignore clinical evidence or their own judgment. On the other hand, “AI fatigue” happens when frequent false alerts make healthcare workers ignore or block AI warnings, which can harm patient safety.
It is important to keep a balance so AI helps but does not replace careful clinical decisions.
AI in healthcare, especially advanced models and the data centers that run them, use a lot of energy. In 2022, AI and cryptocurrency technology used about 2% of the world’s electricity, and this amount is expected to double by 2026. Healthcare organizations aware of environmental issues need to think about the energy costs of using AI and weigh them against the clinical benefits.
Human oversight does not mean every healthcare worker must be an AI expert. Instead, they should know enough about AI’s strengths and limits to understand AI outputs, explain them to patients, and spot possible errors or bias from AI.
Healthcare organizations in the U.S. are advised to create clear AI governance systems. These should include groups with clinicians, IT staff, security officers, compliance leaders, and clinic managers. These groups would review AI vendors, manage risks, check regulations, and keep watching AI’s performance and ethical use.
Tools like Censinet RiskOps™ combine automated risk checks with human review. This fits well with the “human-in-the-loop” process, which mixes automation of routine tasks and risk checks with necessary human decision-making in important clinical choices.
Training staff nonstop is also important. Because healthcare workers are busy and under pressure, AI education should be easy to use and built into daily work instead of being long sessions that staff may only partly attend. Training should include AI ethics, detecting bias, transparency, data privacy, and clinical examples.
Human oversight also helps with the “black box” problem of many AI systems by letting clinicians use their experience and knowledge to judge AI advice, especially in unique or hard cases where AI may fail.
AI does more than help clinical decisions. It also automates many front-office and administrative jobs that take a lot of staff time. Hospital managers, practice owners, and IT leaders need to understand how AI changes workflows to keep services efficient.
Companies like Simbo AI use AI to manage phone calls and answering services. They handle tasks such as scheduling patients, sending appointment reminders, refill requests, and common questions. This takes repetitive calls off receptionists and call centers and improves patient communication.
Across busy healthcare practices in the U.S., AI answering services reduce waiting times, increase first-call problem solving, and make sure important messages quickly get to clinical teams. By automating front-office tasks, clinical staff can focus more on patient care and less on administration.
Organizations like ShiftMed use AI prediction to guess patient numbers and staffing needs. By scheduling shifts and resources based on current data, clinics can reduce staff burnout, lower overtime costs, and improve patient satisfaction.
These staffing tools predict busy times, allowing clinics to hire or change shifts early. This keeps care quality up and reduces wait times and appointment backlogs.
AI helps monitor patients in real time by looking at vital signs, lab tests, and device data. It can send warnings to clinicians about problems like sepsis or heart failure earlier than traditional methods. These AI alerts help reduce reactive care and let staff focus on very sick patients first.
However, managers must prevent alert fatigue by tuning AI systems so alerts are useful and not overwhelming. Human coordination is needed to add AI alerts properly into care plans.
AI also automates many manual processes outside clinical care. Examples include approval of authorizations, insurance claim checks, and compliance reporting. Automation helps leaders see the whole operation, so they can respond fast to resource needs, rule changes, or patient safety issues.
AI technology is playing a growing role in clinical decisions and healthcare operations in the U.S. But AI is not a complete solution; human oversight is still needed to check AI limits, handle ethical problems, and keep patients safe. Challenges like bias, unclear explanations, responsibility, and respect for patient choices need close attention.
Administrators and IT leaders must set up strong AI governance, keep training providers, and balance automation with clinical judgment. AI tools that manage front-office tasks and staffing can improve operations but must fit well with clinical work and protect privacy.
Keeping the right balance—using AI as a tool with humans as decision makers—will help U.S. healthcare practices use AI carefully and support better patient care and sustainable clinical services.
The AI chatbot, part of the Moonrise Initiative, engaged 2,671 parents and increased HPV vaccine scheduling or completion to 7.1% versus 1.8% in controls. It enhanced communication with healthcare providers and effectively addressed vaccine hesitancy, especially in rural areas where parents were 8.81 times more likely to initiate vaccination, highlighting AI’s role in improving preventive care access and overcoming resistance.
Project Mulberry integrates AI and behavioral data from 100 million Apple Watch users to build personalized health tools that track biometrics, provide coaching, and support medication adherence. It includes innovations in food tracking, delivery integration, and non-invasive glucose monitoring, aiming to empower consumer-driven preventive health and facilitate early intervention through real-time data analysis.
AI tools like chatbots reduce barriers such as vaccine hesitancy and limited healthcare access by offering scalable, trusted information and facilitating healthcare engagement. The China HPV vaccine study showed rural parents utilizing the chatbot were substantially more likely to vaccinate, demonstrating AI’s ability to bridge urban-rural disparities in preventive care uptake.
GPT-4 excelled in structured diagnostic tasks (over 90% accuracy) but struggled with open-ended, multi-step clinical management questions, dropping to 51.2% accuracy without multiple-choice options. Its difficulties included handling dosage, contraindications, and real-world judgment, indicating it is not ready for autonomous clinical use and requires refinement with pharmaceutical datasets.
AI promotes equity by targeting underserved populations with personalized, accessible interventions. The successful chatbot deployment in rural China proves AI reduces urban-rural gaps by enhancing health literacy and stimulating provider engagement, offering scalable models to extend preventive services to populations with historically low uptake.
AI agents integrated with biometric and behavioral data can provide personalized coaching, reminders, and support through apps and delivery services, as seen in Apple’s Project Mulberry. This real-time engagement may reduce treatment abandonment, improve health outcomes, and shift care models toward proactive, patient-centered management.
Scalability allows AI interventions to reach large, diverse populations cost-effectively. The HPV vaccine chatbot’s adaptability to new regions and health conditions demonstrates how AI systems can be expanded rapidly to address multiple public health challenges globally while maintaining effectiveness.
Behavioral data enables AI to tailor interventions according to individual habits, preferences, and risks. Project Mulberry’s use of activity, sleep, and biometric metrics exemplifies how such data refines coaching and health decision support, improving prevention strategies and patient engagement.
AI-facilitated communication encourages patients to consult healthcare providers more readily, as seen with 49.1% chatbot users engaging providers versus 17.6% controls. This enhanced dialogue improves vaccine uptake and other preventive actions by resolving hesitancy and building trust.
While AI boosts healthcare outreach, limitations in reasoning and risk of misinformation necessitate cautious integration with human oversight. As GPT-4’s clinical reasoning gaps reveal, over-reliance can erode clinician judgment, underscoring the need for transparent, accountable AI applications that complement rather than replace professionals.